Home › Funds › Morgan Stanley › Vitality Portfolio
Fund family: Morgan Stanley · Filed by MORGAN STANLEY INSTITUTIONAL FUND INC (CIK 836487) · SEC series S000074797
Share classes and tickers: MSVDX (C000233002), MSVEX (C000233003), MSVMX (C000233004), MSVOX (C000233005)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 268 with, 6 against, 0 abstentions (not counted as with management). Shareholder proposals: 4 FOR, 2 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Morgan Stanley’s manager page (139,958 ballot items across 61 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Morgan Stanley | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 96.8% | 250 | 86.0% | 111,214 |
| Backed environmental and social shareholder proposals at US companies | n/a | 1 | 27.9% | 1,130 |
Each ballot item this fund voted is set against the votes of the other Morgan Stanley funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Morgan Stanley funds on 4 items (2.8% of the 143 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Morgan Stanley funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Guardant Health, Inc. | 2026-06-17 | Election of Class II Directors: Manuel Hidalgo Medina | For | WITHHOLD — 3 of 3 Morgan Stanley funds | For | Elected, 75.5% support |
| Doximity, Inc. | 2025-08-28 | To elect two Class I Directors to serve until the annual meeting of stockholders to be held in 2028 or until their successors are duly elected and qualified: Jeffrey Tangney | For | WITHHOLD — 3 of 3 Morgan Stanley funds | For | Elected, 97.0% support |
| Doximity, Inc. | 2025-08-28 | To elect two Class I Directors to serve until the annual meeting of stockholders to be held in 2028 or until their successors are duly elected and qualified: Kira Wampler | For | WITHHOLD — 3 of 3 Morgan Stanley funds | For | Elected, 91.7% support |
| Doximity, Inc. | 2025-08-28 | To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers for the fiscal year ended March 31, 2025. | For | AGAINST — 3 of 4 Morgan Stanley funds | For | Passed (calculated), 96.4% support |
Download all 4 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 86.5% of this fund’s 274 such votes could be given a sector; the other 37 (13.5%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 205 | 6 | 2.9% |
| Industrials | 18 | 0 | 0.0% |
| Technology | 14 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 166 | 0 |
| Audit-related | 31 | 0 |
| Say-on-Pay | 31 | 0 |
| Corporate Governance | 20 | 5 |
| Capital Structure | 12 | 0 |
| Compensation | 10 | 0 |
| Extraordinary Transactions | 5 | 0 |
| Shareholder Rights and Defenses | 3 | 0 |
| Other Social Issues | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Eli Lilly and Company | May 4, 2026 | $259,473 | 10 | 2 |
| argenx SE | May 6, 2026 | $223,473 | 12 | 0 |
| argenx SE | November 18, 2025 | $223,473 | 1 | 0 |
| 10x Genomics, Inc. | June 4, 2026 | $209,017 | 5 | 0 |
| Thermo Fisher Scientific Inc. | May 20, 2026 | $128,669 | 13 | 0 |
| Guardant Health, Inc. | June 17, 2026 | $116,520 | 5 | 0 |
| Ceribell, Inc. | June 2, 2026 | $103,434 | 3 | 0 |
| Enliven Therapeutics, Inc. | June 9, 2026 | $101,240 | 6 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | For | Against |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | For | Against |
| June 1, 2026 | UnitedHealth Group Incorporated | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | Against | For |
| May 13, 2026 | Vertex Pharmaceuticals Incorporated | Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposal | For | Against |
| May 4, 2026 | West Pharmaceutical Services, Inc. | Shareholder proposal regarding an independent Board Chair policy. Shareholder proposal | Against | For |
| May 20, 2026 | Zoetis Inc. | Shareholder proposal to permit shareholder action by written consent. Shareholder proposal | For | Against |
279 ballot items at 33 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Vitality Portfolio (MSVDX) voted at 33 shareholder meetings of 32 companies, on 279 ballot items in all. Where management made a recommendation, the fund followed it on 97.8% of the items and voted against it 6 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 6 shareholder proposals. It voted FOR the board's own proposals more often than Morgan Stanley's funds as a whole (96.8% against 86.0%). It voted differently from most Morgan Stanley funds on 4 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Morgan Stanley’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.